A data management system for structural genomics by Raymond, Stéphane et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
Proteome Science
Open Access Research
A data management system for structural genomics
Stéphane Raymond1,3, Nicholas O'Toole2,3 and Miroslaw Cygler*1,2,3
Address: 1Biotechnology Research Institute, National Research Council, 6100 Royalmount Avenue, Montréal, Québec H4P 2R2, Canada, 
2Department of Biochemistry, McGill University, Montréal, Québec H3G 1Y6, Canada and 3Montréal Joint Centre for Structural Biology, Montréal, 
Québec, Canada
Email: Stéphane Raymond - stephane@BRI.NRC.CA; Nicholas O'Toole - nicholas@BRI.NRC.CA; Miroslaw Cygler* - mirek@BRI.NRC.CA
* Corresponding author    
Abstract
Background: Structural genomics (SG) projects aim to determine thousands of protein structures
by the development of high-throughput techniques for all steps of the experimental structure
determination pipeline. Crucial to the success of such endeavours is the careful tracking and
archiving of experimental and external data on protein targets.
Results: We have developed a sophisticated data management system for structural genomics.
Central to the system is an Oracle-based, SQL-interfaced database. The database schema deals
with all facets of the structure determination process, from target selection to data deposition.
Users access the database via any web browser. Experimental data is input by users with pre-
defined web forms. Data can be displayed according to numerous criteria. A list of all current target
proteins can be viewed, with links for each target to associated entries in external databases. To
avoid unnecessary work on targets, our data management system matches protein sequences
weekly using BLAST to entries in the Protein Data Bank and to targets of other SG centers
worldwide.
Conclusion: Our system is a working, effective and user-friendly data management tool for
structural genomics projects. In this report we present a detailed summary of the various
capabilities of the system, using real target data as examples, and indicate our plans for future
enhancements.
Background
Structural genomics (SG) initiatives aim to determine
thousands of protein structures at an unprecedented rate
[1-4]. These projects have been initiated partly in response
to the massive amount of information that continues to
be generated by the genome sequencing projects. Since
the sequence-structure-function paradigm underpins
modern biology, it would be invaluable for the discovery
of protein structural information to proceed at a pace
comparable to that of the sequence data. Most of the SG
initiatives select as protein "targets" hundreds or thou-
sands of the open reading frames (ORFs) of particular
genomes. These groups have been developing high-
throughput techniques for all steps in the experimental
structure determination pipeline (e.g. cloning, expression,
crystallization), with the goal that a large proportion of
their targets will yield protein structures in a short period
of time. It is anticipated that the new high-throughput
experimental techniques being developed will also affect
"conventional" structural biology laboratories, focusing
on particular proteins or biochemical systems of interest,
by enabling them to rapidly process many more cloned
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constructs or crystallization conditions, for example, than
was possible in the past.
In common with the genome sequencing projects, the
rapid accumulation of large amounts of data by an SG
project renders the conventional method of archiving and
tracking experimental data via laboratory notebooks
highly inefficient. The problem is particularly acute in
structural biology because each step of the experimental
pipeline involves different techniques and results. There is
therefore a need for computerized experimental data
information management systems in structural biology,
and for structural genomics projects in particular. Such
systems, often called Laboratory Information Manage-
ment Systems (LIMS), have been developed in the past
decade for genomics laboratories involved in sequencing
and microarray analysis [5,6]. Structural genomics
presents unique requirements for data tracking systems
and these are outlined in detail in the following section.
We have developed an experimental data management
system for structural genomics, the SPEX Db (Structural
Proteomics EXperimental Database). The system serves
both as a LIMS and also as a tool for SG target selection
and management. It follows a standard three tier client/
server architecture, using Oracle 8i for the database tier
and Netscape iPlanet Web Sever (Enterprise Edition 4.1)
for the server tier. The client tier is expected to be a stand-
ard web browser such as Microsoft Internet Explorer or
Netscape Navigator. The SPEX Db can accommodate any
type of protein targets and is currently used by over 10
structural biology projects throughout Canada. The pri-
mary user of the system is the Montreal-Kingston Bacterial
Structural Genomics Initiative (M-KBSGI; http://
sgen.bri.nrc.ca/brimsg/bsgi.html), which selects as targets
the ORFs of bacterial genomes such as E. coli K12 and the
pathogenic E. coli strains O157 and CFT073. In this paper
we describe the SPEX Db in detail, with reference to its
actual use by the M-KBSGI. Central to the system is the
Oracle-based relational database. We illustrate the data-
base schema and describe the user interface to the data. In
addition, we describe the interactions of the system with
external sources of data. These facets of the system aid SG
target selection and enable monitoring of the status of an
SG project, both at the level of individual targets and as a
whole. The target selection and external interaction facets
of the SPEX Db differentiate it from other data manage-
ment systems recently developed for structural genomics,
such as SPINE [7], SESAME [8] or HalX [9], which are pri-
marily devoted to experimental data tracking, as for a tra-
ditional LIMS system.
Results and Discussion
Requirements of an SG data management system
An ORF selected as a structural genomics target proceeds
along the general experimental pipeline depicted in Figure
1. This flowchart, from target selection to structure deter-
mination, is relatively standard for structural genomics
groups, up to the "Quality Control" stage. A particular SG
lab may not possess the facilities for both the NMR and X-
ray methods of structure determination, so that one of
these branches after quality control would not be fol-
lowed. The stage of "Proteolysis" in the pipeline figure
indicates the commonly used technique of applying lim-
ited proteolysis to identify protein domains suitable for
structural analysis [10]. New constructs for the target ORF
suggested by the proteolysis will rejoin the experimental
pipeline at the "Cloning" stage (hence the dashed arrow).
At each of the steps in Figure 1 different experimental pro-
cedures are used, resulting in a variety of experimental
data unique to the step. This heavily influences the design
of the database schema related to the tracking of experi-
mental data, as described in the following section.
In addition to the LIMS-like archiving of experimental
data for active SG targets, a data tracking system for struc-
tural genomics should serve as a resource for target selec-
tion. Methods of target selection for SG projects vary
widely between groups [11] but there are certain essential
pieces of information on targets, such as the presence of
homologous structures already determined, that should
be readily available when selecting targets from a pool of
potential target ORFs. Most of this information is found
in external public databases. The key information stored
on targets is also crucial for active targets. For example, the
progress of homologous SG targets among other SG labo-
ratories should be monitored regularly to avoid unneces-
sary work. Experimental difficulties with a particular
target may be ameliorated by investigation of its putative
domain structure, so that alternative constructs for the
selected ORF may be tried. The requirement for up-to-date
and extensive information on targets also influences the
design of the database underlying our SG data manage-
ment system.
As important as the database schema is the interaction of
its users with the data stored. Workers in the laboratory
should be presented with an interface that enables quick
inputting of experimental data that is detailed but also as
unambiguous as possible. Where there are a discrete
number of possible experimental conditions to be entered
(such as the name of purification protocol used for a tar-
get) drop-down menus should be preferred over manual
typing, so that possible ambiguities do not thwart later
mining of the stored data. The user interface should also
enable easy generation of reports from the database (such
as a list of all targets currently at the "Crystallization" stageProteome Science 2004, 2 http://www.proteomesci.com/content/2/1/4
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from a particular organism) but without the need for
manually inputting SQL queries. Our user interface was
designed in the light of requirements such as these.
Database design
Figure 2 presents a diagram of the schema of the database
underlying the SPEX Db. All tables are linked with foreign
keys to ensure data integrity.
For information on targets there are two main tables,
PROJECT and TARGET. The PROJECT table contains
information on separate projects and is used to group the
targets of a project together appropriately. The database is
designed to support multiple SG projects and there are
over 10 separate projects in our working data manage-
ment system, although the M-KBSGI project provides a
large majority of the targets. The TARGET table is used to
hold information on a target, such as source organism,
molecular weight, and references to the NCBI and ExPASy
databases. These data on targets are useful for target selec-
tion and management of active targets, as explained in the
previous section. The M-KBSGI has loaded all of the ORFs
of several bacterial genomes into the TARGET table. Active
targets are selected from these genomes with the help of
the up-to-date target information provided by the system.
Other projects choose to load only targets that have
already been selected. The TARGET table also accommo-
dates user annotation of targets and the status of work
(the point along the experimental pipeline) for each tar-
get. The table is linked to the PROJECT table with a for-
eign key and a constraint of one to many on the
project_id.
Three tables, PLASMID, OLIGO and GLYCEROL, track the
progress of the cloning step of the experimental pipeline.
The PLASMID table contains information about the clon-
ing strategy and references to the forward and reverse oli-
gonucleotide primers. Information about each primer is
stored in the OLIGO table. The GLYCEROL table is used
to keep information about the physical location of frozen
glycerol stocks of bacterial cultures carrying the plasmid.
The PLASMID table is linked to the TARGET table with a
foreign key and a constraint of one to many on the
target_id (i.e. for a single target one can create many dif-
ferent plasmids, corresponding to different cloning strate-
gies or alternative constructs.)
The production step has one table, called PRODUCTION.
This table contains information about the cell culture,
incubation temperature and various other experimental
parameters. The PRODUCTION table is linked to the
PLASMID table with a foreign key and a constraint of one
to many on the plasmid_id.
The PURIFICATION table contains information about the
cell lysis method and subsequent chromatography
The structural genomics experimental pipeline Figure 1
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experiments used to purify the protein. This table is linked
to the PRODUCTION table with a foreign key and a con-
straint of one to many on the production_id.
After purification, quality control is performed on a pro-
tein solution. Experimental results from SDS-PAGE gels,
mass spectrometry and dynamic light scattering are stored
in a table called QUALITY. The QUALITY table is linked to
the PURIFICATION table with a foreign key and a con-
straint of one to one on the purification_id. Similarly, a
PROTEOLYSIS table tracks the limited proteolysis experi-
ments and is linked to the PURIFICATION table with a
foreign key and a constraint of one to one on the
purification_id.
Along the X-ray crystallography path of structure determi-
nation, the CRYSTAL table stores information on crystal-
lization experiments and the DATCOL table contains X-
ray data collection parameters, such as the radiation wave-
length and cell parameters, etc. Final refinement statistics
are stored in the STRUCTURE table. The intermediate
STRUCT_DATA table is implemented to enable one struc-
ture entry for many X-ray data collections, allowing, for
example, complete recording of multiple wavelength
anomalous diffraction (MAD) data collection. Experi-
mental information for structure determinations by NMR
methods is stored in the analogous tables NMRDATCOL
and NMRSTRUCTURE.
Each of these tables containing experimental information
for targets along the experimental pipeline has a foreign
key to the user_id in a USER table, a listing of laboratory
members. The user_id reference is used to check if the user
has permission to edit or delete the corresponding entry
in an experimental data table (see Access Control, below).
In addition to the experimental tables which track the
work in progress on each target, the database contains
other tables linked by foreign keys to the TARGET table.
For each target in the database, the TOPHIT and
Database schema Figure 2
Database schemaProteome Science 2004, 2 http://www.proteomesci.com/content/2/1/4
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SGTBLAST tables contain weekly-updated information on
homologous protein sequences either in the PDB or in
progress within other SG laboratories, respectively. Other
auxiliary tables exist, such as PROTOCOL and BUFFER,
which allow for detailed descriptions of standard experi-
mental protocols and routinely used chemical buffers,
respectively.
External interactions of the system
The SPEX Db exchanges information with a variety of
external resources. For each target in the database, corre-
sponding entries in the SWISS-PROT/TrEMBL, NCBI,
InterPro, and many other external databases are available
via HTML links. Information within these databases (and
further cross-referenced to others) aids in the selection of
targets and enables quick access to potentially useful data
on active targets, such as putative domain structures, isoe-
lectric points and cofactors, for example.
It is crucial for structural genomics laboratories to regu-
larly check the Protein Data Bank (PDB) for known struc-
tures of homologous proteins. The SPEX Db runs a weekly
script for this purpose: for each target sequence in the
database, a sequence similarity search using BLAST is
made against the latest database of protein sequences in
the PDB, downloaded from ftp://ftp.rcsb.org/pub/pdb.
The TOPHIT table of the database is updated using the
results of the search. Any target for which a new most
homologous hit is found in the PDB is listed in an email
distributed to all users of the SPEX Db. An E-value homol-
ogy cut-off of 0.1 is used in the similarity search, corre-
sponding to a minimum sequence identity of
approximately 25%. Based on the results of the weekly
search and the level of similarity between targets and new
structures in the PDB, work may be stopped on a target
because the structure of a homologous target has been
solved.
The M-KBSGI, the structural genomics project supplying
the majority of targets to the SPEX Db, also participates in
the global monitoring of structural genomics targets.
There is an open exchange of information on the targets of
17 SG laboratories worldwide in a standard XML format.
The XML format requires SG groups to report the amino
acid sequence and latest experimental status of their tar-
gets. Groups can also provide additional information
such as the name of the target protein, source organism,
and links to corresponding entries in other databases. The
data from all groups is available from a central database
maintained by the PDB [12] (TargetDB, http://tar
getdb.pdb.org). Our initiative is one of the 17 SG labora-
tories reporting target information. Each week, a script
harvests information from the database on experimental
status for all selected targets and produces an XML file in
the required format. The file is available in machine-read-
able format from the M-KBSGI website and is included in
the global XML file assembled by TargetDB.
In order to track the progress of similar SG targets from
other groups, the SPEX Db runs another weekly script. A
FASTA format database of sequences is assembled from
the data in the central XML file, downloaded from Tar-
getDB. Each SPEX Db target sequence is compared against
the database of SG sequences with BLAST. For the hits that
are found, if any, all information given in the XML format
is extracted and presented in an HTML report. Some key
information from the hits, such as the status of the most
advanced homologous SG target, is stored in the SGT-
BLAST table of the database and updated after the weekly
search. If the most advanced experimental status among
homologous SG targets changes for a target sequence in
the SPEX Db, the target id and the change in status is
reported in a weekly email distributed to all users of the
SPEX Db. Like the search for homologous targets in the
PDB, an E-value cut-off of 0.1 is used for the search against
TargetDB. These weekly global comparisons rapidly iden-
tify locally less advanced targets and facilitate stoppage of
work that duplicates more advanced efforts around the
world.
User interface
Users of the SPEX Db interact through a web-based inter-
face built on top of Netscape iPlanet Web Sever, Enterprise
Edition 4.1. We use server side JavaScript code to do all
transactions with the database and format the HTML doc-
ument sent to the client browser.
A detailed description of all facets of the user interface is
impractical for this report. In this section we illustrate
examples of four commonly used types of web pages in
the system.
Target View
Figure 3 is a screenshot for seven targets in the "Target
View" mode of the SPEX Db. The smaller screenshot insets
in the figure show the pages obtained by clicking on vari-
ous links and are included for illustrative purposes only.
Readers are encouraged to try all aspects of the system
available from the Target View (apart from the Tree View,
see below) by visiting the M-KBSGI website http://
sgen.bri.nrc.ca/brimsg/bsgi.html and clicking on "List all
targets" or "Target search". Information on each target
occupies a row. The first column shows an index for that
target based on the type of search that was performed.
Clicking on the globe icon in the "Links" column results
in a pop-up window of a wide range of external links
related to the target, as referred to in the previous section.
The target name is a link to the Target Page for that target,
which contains more detailed information on the target
than in the rows seen in Figure 3, but on a separate page.Proteome Science 2004, 2 http://www.proteomesci.com/content/2/1/4
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The background of the target name is colored according to
the legend at the top of the page, for the various states of
the ORF as a target within the particular SG group using
the SPEX Db. The "#AA" column contains the length, in
amino acid residues, of the target ORF. Clicking on that
number results in the target amino acid sequence from
NCBI. The "Group" column displays a code correspond-
ing to the laboratory within the M-KBSGI that is working
on that target. Important for targets that are active within
the laboratory is the "Tree" column. Clicking on the tree
icon yields the Tree View for the target, which is discussed
below. The "Stage" column indicates the latest experimen-
tal state for the target, in terms of the pipeline in Figure 1.
If the structure of the target has already been determined
and is deposited in the PDB, the PDB code is displayed.
The following four columns display weekly-updated data
from the search for homologous PDB or SG sequences, as
described earlier. The PDB code of the most similar PDB
sequence found (if at least one is found) is shown in the
"Top PDB" column, and it is also a link to the correspond-
ing PDB entry. The next column shows the percentage
sequence identity and overlap of this top PDB hit. The
"Top SGT" column shows the percentage identity and
overlap of the most similar SGT sequence, and the "Top
SGT Status" column shows the experimental status (as
reported in the worldwide SG XML file) of the most
advanced SGT hit.
The "# TMHs/SignalP" column shows data on the pre-
dicted presence of transmembrane helices or signal
Target view Figure 3
Target viewProteome Science 2004, 2 http://www.proteomesci.com/content/2/1/4
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peptide sequences for the target ORF, calculated using the
TMHMM [13] (Krogh et al., 2001) and SignalP [14]
(Nielsen et al., 1997) programs. The first number in the
column is the number of putative transmembrane helices,
and the second symbol, either a "Y" or an "N", corre-
sponds to the presence or absence of a predicted signal
sequence, respectively. Clicking on either presents the user
with a more detailed page about the predictions. This data
is primarily used during target selection to screen out at a
glance potential target ORFs that contain membrane-
spanning regions, whose structures are notoriously diffi-
cult to obtain. The "Paralogs" column indicates the
number of homologous sequences within the pool of
potential targets for the M-KBSGI. (In this sense the term
"paralogs" is used differently from the usual connotation,
that of homologous sequences within the same pro-
teome.) Clicking on the number produces a list of the tar-
get names for the "paralogous" targets. Finally, the
"Description" column contains the description (from the
NCBI) of the function of the target ORF.
Tree View
From the Tree View users can access the experimental data
that is entered into the experimental data tables described
earlier. In Figure 4 we show the Tree View for a target with
a solved structure, so that data has been entered in each of
the tables from PLASMID to STRUCTURE. (This target
structure was solved by X-ray crystallography). From left
to right the columns in the tree view follow the stages in
the experimental pipeline (Fig. 1). By clicking on the
entries in the Tree View, data in the tables corresponding
to each of the stages can be viewed from separate web
pages, as indicated by the smaller screenshot insets in Fig-
ure 4. Tree View entries are coloured according to whether
the experiment to which it refers is in progress or com-
pleted or cancelled. Because of the one to many con-
straints in the database schema for sequential
experimental data tables, many tree view entries corre-
sponding to one PLASMID entry can accumulate at later
stages in the pipeline. Users can view an experimental data
entry, edit one (with the correct permission), or add a new
entry corresponding to a new experiment, according to
the option selected above the Tree View in Figure 4.
Adding a Production entry
The partially completed web form in Figure 5 is an exam-
ple of the forms used to add experimental data to the Tree
View. This form appears if a user wishes to add data corre-
sponding to a Production experiment. (The data entered
is actually that of the Production entry leading to the
structure in Figure 4.) The layout of the form is identical
to that of the pages that simply display data that has been
entered. At the top right of the page is the user_id of the
laboratory member entering the data. Only this person
can further edit the entry. In revisiting past experiments it
is useful to know the identity of the laboratory member
entering experimental data should any additional infor-
mation be required. The unit of data required for each
numerical entry is explicitly indicated, and note that for
three fields (Label, Culture Medium and Inducer Type),
drop down menus containing the possible entries are pro-
vided. These features serve to make the experimental data
entered as unambiguous as possible. Importantly, there is
also additional room for the user to insert notes and com-
ments regarding any unusual or noteworthy results of the
experiment.
Searching the database
Searches for entries in all experimental data tables (e.g.
DATCOL entries, corresponding to X-ray data collections,
or proteolysis results) can be performed, resulting in
pages listing entries in formats analogous to the Target
View described above. Searches can be performed based
on the ids of the experiments, their status, or the users
who performed them. Searches for targets can be made
with combinations of 14 different target criteria via an
extensive Target Search page (Figure 6). A smaller number
of target search criteria are available for the public via
http://sgen.bri.nrc.ca/brimsg/bsgi.html. In addition, there
is a "Search All" page in which users can combine criteria
from different tables for more extensive searches without
the need for manual input of SQL queries. These queries
can be stored for future use. The user interface also allows
users access to data in the auxiliary tables (such as PRO-
TOCOL) via a search interface.
Access control
Access to the user interface is controlled by the identifica-
tion (login name and password) and authority level of a
user. Authority levels range from 0 to 9. Users with an
authority level of 0 do not have access, and those with
level 1 have read only access. Users with authority level 2,
the majority of all lab members, can read all pages in the
system, but can edit or delete only the entries that they
have created. Authority levels higher than 3 are for admin-
istrative tasks. For security purposes, if a user logged in to
the web server is inactive for an hour, the user is automat-
ically logged out, and must re-enter his or her password to
resume the session.
Under the present system users in a particular project with
authority levels 2 and above can view and/or add data
belonging to another project. We will avoid this unwel-
come scenario by implementing a more complex access
control scheme under which it will be possible to restrict
all access to a subset of the data in the database. The new
scheme takes into account in a most general way the dif-
fering roles (and differing access requirements) for work-
ers in large collaborative structural genomics projects.Proteome Science 2004, 2 http://www.proteomesci.com/content/2/1/4
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Future developments
The design of our database and associated web interface
has resulted in a user-friendly system that can be of tre-
mendous benefit to structural genomics initiatives, as it
has proven to be for the Montreal-Kingston Bacterial
Structural Genomics Initiative. However, as the field of
structural genomics evolves, so too must the flexibility of
SG data management systems such as ours. Our database
schema reflects very well the traditional SG experimental
pipeline, but it is apparent that more sophisticated exper-
imental relationships will in the future need to be accom-
modated by the schema underlying any SG data
management system. For example, groups may want to
combine different experiments at some point along the
pipeline into a new experiment (such as for the co-crystal-
lization of a protein complex). Many-to-one relationships
such as these along sequential experimental steps are not
easily dealt with in the present system. For another exam-
ple, a gift of a purified protein from collaborators outside
a user of the SPEX Db requires under the present schema
the addition of "dummy" entries in the database tables
from PLASMID up to PURIFICATION. Other information
systems that have been developed to serve SG initiatives,
such as SPINE [7], SESAME [8] or HalX [9] are also ham-
pered by similar underlying schema. Database design for
SG data management systems should be made as flexible
as possible for the future needs of SG groups, so that, for
example, many-to-one relationships along the experimen-
tal pipeline such as we have mentioned are accommo-
dated. We have participated in the development of a
Tree view Figure 4
Tree viewProteome Science 2004, 2 http://www.proteomesci.com/content/2/1/4
Page 9 of 11
(page number not for citation purposes)
Production entry form Figure 5
Production entry formProteome Science 2004, 2 http://www.proteomesci.com/content/2/1/4
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prototype schema with collaborators at the European
Molecular Biology Laboratory and elsewhere that seeks to
address such issues (see http://www.ebi.ac.uk/msd-srv/
docs/ehtpx/lims/downloads.html for further
information).
Other areas of future enhancements of the SPEX Db
include automatic interaction with laboratory robots,
resulting in real time automatic input of experimental
data. The graphical documentation of experiments, such
as pictures of gels, will be included in the experimental
result pages of the user interface. Users may experience
long response times to queries accessing multiple tables
from the search interfaces. We are implementing some
changes to the code and computer hardware to speed up
such searches. Laboratories may wish to use the proteins
produced by an SG endeavor for more than just structure
determination. For example, purified proteins can be
introduced into an appropriate host for polyclonal anti-
body production. Such experiments correspond to a new
Target search Figure 6
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path in the SG pipeline (Fig. 1) after the "Quality Control"
stage. Since antibody production is in the planning stage
among some users of our system we will introduce the
new database tables and web pages required to accommo-
date the accompanying information. As discussed earlier,
we also intend to implement a more sophisticated access-
control model.
Availability
Structural biology and structural genomics laboratories
are welcome to contact the authors for full access and use
of the SPEX Db. In addition, the database underlying the
system can be established locally with code for table crea-
tion commands and the associated data dictionary, avail-
able by request from the authors.
Authors' contributions
SR designed the database and programmed the user inter-
face. NO developed tools for sequence comparisons and
other external interactions of the system and drafted the
manuscript. MC conceived of the project and participated
in its design and coordination. All authors have read and
approved the final manuscript.
Acknowledgements
The authors wish to thank Hervé Hogues for assistance in database design 
and application programming. We also thank Xeuli Li, Nomair Naeem, Gre-
gory Jarrett and Jeffrey Rasmussen for the development of miscellaneous 
programming tools and graphical images. This work was in part supported 
by CIHR grant No. 200103GSP-90094-GMX-CFAA-19924 to MC.
References
1. Terwilliger TC, Waldo G, Peat TS, Newman JM, Chu K, Berendzen J:
Class-directed structure determination: foundation for a
protein structure initiative. Protein Science 1998, 7:1851-1856.
2. Kim S: Shining a light on structural genomics. Nat Struct Biol
1998, 5(Suppl):643-645.
3. Montelione GT, Anderson S: Structural genomics: keystone for
a Human Proteome Project. Nat Struct Biol 1999, 6:11-12.
4. Burley SK, Almo SC, Bonanno JB, Capel M, Chance MR, Gaasterland
T, Lin D, Sali A, Studier FW, Swaminathan S: Structural genomics:
beyond the human genome project.  Nat Genet 1999,
23:151-157.
5. Imbert MC, Nguyen VK, Granjeaud S, Nguyen C, Jordan BR: 'LAB-
NOTE', a laboratory notebook system designed for aca-
demic genomics groups. Nucl Acids Res 1999, 27:601-607.
6. Brazma A, Sarkans U, Robinson A, Vilo J, Vingron M, Hoheisel J, Fel-
lenberg K: Microarray data representation, annotation and
storage. Adv Biochem Eng Biotechnol 2002, 77:113-39.
7. Goh CS, Lan N, Echols N, Douglas SM, Milburn D, Bertone P, Xiao R,
Ma LC, Zheng D, Wunderlich Z, Acton T, Montelione GT, Gerstein
M: SPINE 2: a system for collaborative structural proteomics
within a federated database framework. Nucleic Acids Res 2003,
31:2833-8.
8. Zolnai Z, Lee PT, Li J, Chapman MR, Newman CS, Phillips GN Jr, Ray-
ment I, Ulrich EL, Volkman BF, Markley JL: Project management
system for structural and functional proteomics: Sesame. J
Struct Funct Genomics 2003, 4:11-23.
9. HalX – Free-source Laboratory Information Management
System (LIMS) software  [http://halx.genomics.eu.org/]
10. Koth CM, Orlicky SM, Larson SM, Edwards AM: Use of limited pro-
teolysis to identify protein domains suitable for structural
analysis. Methods Enzymol 2003, 368:77-84.
11. Linial M, Yona G: Methodologies for target selection in struc-
tural genomics. Prog Biophys Mol Biol 2000, 73:297-320.
12. Westbrook J, Feng Z, Chen L, Yang H, Berman HM: The Protein
Data Bank and structural genomics.  Nucl Acids Res 2003,
31:489-491.
13. Krogh A, Larsson B, von Heijne G, Sonnhammer E: Predicting
transmembrane protein topology with a hidden Markov
model: application to complete genomes.  J Mol Biol 2001,
305:567-580.
14. Nielsen H, Engelbrecht J, Brunak S, von Heijne G: Machine learning
approaches for the prediction of signal peptides and other
protein sorting signals. Protein Engineering 1997, 10:1-6.